
ã圌ãã¯ç§ãã¡ã«åãã€ãããïŒ ã¬ã ãã·ãã«æäžæ°æéåŸã«æ»äº¡ãã59æ³ã®åŠ»ãèªã
å èšäºã¯ãã¡ããã/Click here to read the original article.
劻ã®ã·ã£ãã³ã«ããã°ããã€ã±ã«ã»ãã«ã°ãªã ã®å»çèšé²ã«ã¯ãã¬ã ãã·ãã«ä»¥å€ã«ããã€ã±ã«ã®äž»æ²»å»ã¯ãã€ã±ã«ã«ã»ãšãã©äœã®æ²»çãæœããªãã£ãããšãèšãããŠããã仿¥ãã·ã£ãã³ã¯ãå€«ã®æ»ã«ã€ãªãã£ããšä¿¡ããCOVID-19ã®ç é¢ãããã³ã«ã«ã€ããŠãäžè¬ã®äººã ã®èªèãé«ããããšããŠããã
2021幎8æã53æ³ã®ãã€ã±ã«ã»Eã»ãã«ã°ãªã ãšåŠ»ã·ã£ãã³ã¯çµå©29åšå¹Žãè¿ããã°ããã§ã10æã«åšã®çµå©ãæ§ããŠããã
å è»äººã§2å ã®ç¶ã§ãããã€ã±ã«ã¯ãè¯ã倫ãè¯ãç¶èŠªãã§ãããäœæã«ã¯ãŽã«ããæ¥œããã§ããã
ãããããã®æãå³èŠé害ãåŒåžå°é£ãé žçŽ æ¿åºŠã®äœäžãçµéšãããã€ã±ã«ã®éåœã¯åçã«å€ãã£ãã2021幎8æ17æ¥ã圌ã¯COVID-19ãšèšºæãããæ é·ãããµã¹å·ãã©ãŒããŒã«è¿ããã©ã¹å°åå»çã»ã³ã¿ãŒã«å ¥é¢ããã
2æ¥åŸã®8æ19æ¥ãåœŒã¯æ»äº¡ããã
ã·ã£ãã³ã»ãã«ã°ãªã ã¯ãDefenderãçŽã®ã€ã³ã¿ãã¥ãŒã§ããã€ã±ã«ãå ¥é¢ãããšãããã圌女ãä»ã®å®¶æã¯é¢äŒãçŠãããããã€ã±ã«ãåããŠããæ²»çã«ã€ããŠãç¥ããããŠããªãã£ããšèªã£ãã
ã·ã£ãã³ããã«ãããšããã€ã±ã«ã®å»çèšé²ã«ãããšãå»åž«ãã¡ã¯ãã€ã±ã«ã«ã»ãšãã©æ²»çãæœãããã¯ã¯ãã³æªæ¥çš®ã§ããããšã匷調ããŠãããšããããã€ã±ã«ãåããæ²»çã«ã¯ãè«äºã®çã«ãªã£ãŠããã¬ã ãã·ãã«ãšããè¬ãå«ãŸããŠããã
仿¥ãã·ã£ãã³ã¯ãå€«ã®æ»ã«ã€ãªãã£ããšä¿¡ããCOVID-19ç é¢ã®ãããã³ã«ã«ã€ããŠãäžéäžè¬ã®èªèãé«ããããšããŠããã圌女ã¯èªåã®è©±ãè£ä»ããèšå€§ãªå»çææžããDefenderããšå ±æããã
ãççŸãããå»çèšé²ã«ã¯ãå€ãã®ã®ã£ãããããã£ã
ã·ã£ãã³ã¯ããã€ã±ã«ãšåæã«ç æ°ã«ãªã£ããã圌女ã¯ããã«å埩ãããšèªã£ããäžæ¹ããã€ã±ã«ã¯å¯ãããã®ãŸãŸã ã£ããã·ã£ãã³ã¯ããã€ã±ã«ã¯ä»¥åã¯å¥åº·ã§è¬ã飲ãã§ããªãã£ããã圌ã®åŒåžå°é£ããæãããªãã911ã«éå ±ããããšã«ãªã£ããšèªã£ãã
ãç§ã«èµ·ãã£ãææªã®ããšã¯ã911ã«é»è©±ããããšã§ãããšã·ã£ãã³ã¯èšã£ããããã€ã±ã«ã«ãšã£ãŠæåã®ããšãããŠããã€ããã ã£ãããããææªã®ããšã ã£ããšããã£ããã§ããã
ãã€ã±ã«ã¯ãã©ã¹ã»ãªãŒãžã§ãã«ã»ã¡ãã£ã«ã«ã»ã»ã³ã¿ãŒã«éã°ãããããã®ç é¢ã¯ã·ã£ãã³æ°ã ãè©å€ãææª ãã ã£ãã圌女ã¯ãç é¢åŽããã€ã±ã«ã®è»¢é¢é¡ããæåŠããå ¥é¢åŸãäŒãããŠãããªãã£ããšéé£ããã
ç é¢ãšã®ã³ãã¥ãã±ãŒã·ã§ã³ã¯éãããŠããããé»è©±ãããŠããçè·å©Šã¯ã·ãã亀代äžã ãšããå¿ãããŠè©±ãã§ããªããšèšãã ãã§ãããã
å»åž«ãšãã€ã±ã«ãšã®ãããšããéãããŠãããšã·ã£ãã³ã¯èšããã圌ãã¯ãã 圌ãéšå±ã«çœ®ãå»ãã«ããŠãå»ççãªããšãèãããã«iPadããã³ãšçœ®ããã ãã§ãã"ã
ã·ã£ãã³ã«ããã°ããã€ã±ã«ã®æ²»çã«ã€ããŠåœŒå¥³ãç¥ã£ãããšã®ã»ãšãã©ã¯ãåœŒã®æ»åŸã«å ¥æããå»çèšé²ããåŸããã®ã§ããã
ã·ã£ãã³ããã¯ããã©ã¹ã»ãªãŒãžã§ãã«ã®å»åž«ãããã€ã±ã«ã¯å æ°ã ããšåœŒå¥³ã«èšã£ãäŸã«ã€ããŠèšåããã
ã·ã£ãã³æ°ã¯ãç é¢ããã€ã±ã«ã«å¯Ÿã㊠ãäœãããªãã£ã ãããšãèšé²ããæããã«ãªã£ããšèªã£ãã圌女ã¯èšã£ãïŒ
ã忥ã¯ãåºæ¬çã«é žçŽ åžå ¥ä»¥å€ã¯äœãããŠãããŸããã§ãããç¿æ¥ãèžéšã¬ã³ãã²ã³ãæ®ããå»åž«ããã¿ãã³å€ãäžãããã«ã«ããèŠãŠãã茞液ããããã©ããããããããªãã
ãè¡æ ã®ããã«ããããã¯ã¹æ³šå°ãæã¡å§ãããè¡æ ã¯ãªãã£ãã®ã«ããªãïŒãªãã€ã³ã¹ãªã³ãæäžããã®ãïŒåœŒã¯ç³å°¿ç ã§ã¯ãªãã£ãã
ãã¬ã ãã·ãã«ãæäžããã以å€ã¯ãã
ã¬ã ãã·ãã«ã¯COVID-19æ£è ã®æ»äº¡ãè² å·ã«é¢ä¿ããŠããããCOVID-19ç é¢ã®ãããã³ã«ã®ããšã§ã¯æ£è ã«æ®éã«æäžãããŠããã
ã·ã£ãã³ã«ããã°ãèšé²ã«ããã°ããã€ã±ã«ã¯æ»äº¡åœæ¥ã«ã¬ã ãã·ãã«ãæäžãããŠããããããã圌女ã®åæ³ã«ããã°ããã®æ¥ã®æ£åã«å€«ãšé»è©±ã§è©±ãããšãã圌ã¯å±éºãªå åã瀺ããŠããªãã£ãã
ã圌ã¯ç§ã«é»è©±ããŠããŠãç§ã¯å®éã«åœŒãšè©±ãããšãã§ããŸãããããŸãé·ãã¯è©±ããŸããã§ãããã人工åŒåžåšã¯ã€ããŠããŸããã§ããã圌ã¯è¯ããªã£ãŠããŸããããšã·ã£ãã³ãåäŸãã¡ã«é»è©±ããŠã"å æ°ããã ã£ããå®¶ã«åž°ã£ãŠããã£ãŠããšãŠãè奮ããŠããŸãããã
ãããããã®æ¥ã®ååŸããã€ã±ã«ã«ã¯ã¬ã ãã·ãã«ãæäžããããã·ã£ãã³ã«ãããšãæ°æéåŸãçè·å©Šããé»è©±ãããããã€ã±ã«ãç¡åå¿ã§çºèŠããããšããã
ãç§ã¯ãã¹ããªãã¯ã«ãªããŸãããã倧äžå€«ã§ããïŒã©ãã«ããã®ïŒã©ããã£ãŠé£çµ¡ãåãã°ããã®ïŒåœŒå¥³ã¯ãã ãããããªãã ããšèšã£ãããããŠã圌女ã¯ç§ã«é»è©±ãåã£ãã
ã·ã£ãã³ã®æ¯åã¯ãã©ã¹ã»ãªãŒãžã§ãã«ã«é»è©±ãããã€ã±ã«ã亡ããªã£ãããšãåãããããããããå®¶æã®å°é£ã¯ããã ãã§çµãããªãã£ãã
ãCOVIDã ãšèšãããã®ã§ããšã³ããŒãã³ã°ããããŸã§ãã€ã±ã«ã«ã¯äŒããŸããã§ããããšã·ã£ãã³ããã
ã·ã£ãã³ã¯ã倫ãã¯ã¯ãã³æªæ¥çš®ã§ãã£ãããšãã圌ãåããæ²»çã«äžåœ¹è²·ã£ããšèããŠãããšèªã£ãã圌女ã¯ããã€ã±ã«ãCOVID-19ã¯ã¯ãã³ã«å¯ŸããŠ ãæ é ãã§ãããæ¥çš®ã«æ¶æ¥µçã§ãã£ãããšããããŠç é¢åŽããããèªèããŠããããšãèªã£ãã
圌ã®ã«ã«ãã«ã¯ããã¯ã¯ãã³æªæ¥çš®ãããæªæ¥çš®ãããæªæ¥çš® ããšæžãããŠããŸããããã«ã¯ ãã¯ã¯ãã³ãä¿¡çšããŠããªã ããšãŸã§æžãããŠããŸãããšã·ã£ãã³ã
圌ãã¯å®å šã«åãã€ããŠãã
ã·ã£ãã³ã¯ããã€ã±ã«ã®æ»åŸãç é¢ã¯åœŒå¥³ãšåœŒå¥³ã®å®¶æãæçµ¶ãããšèªã£ãã
ã圌ãã¯ç§ãšè©±ãããšãããç§ã®é»è©±ã«ãåºãããšããŸããã§ããããç§ã¯äœåºŠãé»è©±ãããŠãäœãèµ·ãã£ãã®ã誰ãã«æããŠã»ãããšæé¡ããã®ã«ã誰ãæããŠãããªãã£ããç é¢ã¯ãã®åŸãåœŒå¥³ã«æªæãã®å»çè²»ãè«æ±ãå§ãããšåœŒå¥³ã¯èšã£ãã
圌女ãç é¢é¢ä¿è ãšè©±ãããšãã圌ãã¯åœŒå¥³ã誀解ãããããã€ã±ã«ã®éºäœãæ€èŠããŠãããæš©å©ãããã«ãããããããå°å åœå±ã¯ ã6ïœ8ã«æé ããŠãã ããããéºäœãåºãŠãããŸã§ããã ãåŸ ããªããã°ãªããªãããšèšã£ãå»åž«ããããšããã
ãæ³åŸã§ã¯2é±é以å ã«æ€æ»ãããªããã°ãªããªãã®ã«ãå®éã«å ±åæžãæã«ãããŸã§ã«6ïœ8ã«æããããããšããããã§ããã§ãã圌ãã¯ãããããªããã°ãªããªãããéºäœãå ¬éããªããã°ãªããªãããããã圌ãã¯ç§ãã¡ã«åãã€ããç§ãã¡ã¯åœŒããä¿¡çšããã®ã§ãããšã·ã£ãã³ã¯èšã£ãã
ãã®ä»£ããã«ãæ¿åºåºè³ã®COVID-19éºææ¯æŽåºéããã€ã±ã«ã®æ»ã«å¯ŸããŠ1äžãã«ã®æ¯æããç³ãåºããšã·ã£ãã³ã¯èšã£ãããæ»äº¡èšŒææžã«COVIDã®èšèŒãããã°ã1äžãã«ãŸã§æ¯çµŠãããšã®ããšã§ãããç§ã¯ ããããªãéã¯çµ¶å¯Ÿã«åãåããªã ããšèšã£ããã§ããã
代ããã«ã·ã£ãã³ã¯ãåããããªçµéšãããå®¶æã®ããã«ãå FedsGroup Freedom Foundationã«åå ããæè·è ãšãªã£ãããã®æè·å£äœã«åå ããããšã§ãã·ã£ãã³ã¯è°å¡ãåŒè·å£«ãä»ã®COVID-19ç é¢ãããã³ã«ã®è¢«å®³è ã®å®¶æãšäŒãããã«ãªã£ãã
ãèŸãããšã§ãããç§ãã¡ãçµéšãããããªèŠãã¿ãä»ã®æãã人ã«å³ãã£ãŠã»ãããªãã®ã§ãããšã·ã£ãã³ã¯èšãããç§ã¯éãç¶ããããšæããŸãããCOVIDã®ããã§æ»ãã ãšæãããããªãã圌ã¯ç é¢ã§æ»ãã ãã ã圌ããåœŒãæ®ºãããã ãã